-
-
-
-
-
-
-
Iovance Biotherapeutics (IOVA) Misses Q1 EPS by 5c ; Offers Guidance
-
-
-
-
-
-
-
Iovance Biotherapeutics Highlights Business Achievements, Pipeline Milestones, and Third Quarter 2025 Results
-
-
-
-
-
-
-
IOVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Iovance Biotherapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
-
-
-
-
-
-
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 14, 2025 in Iovance Lawsuit - IOVA
-
-
-
-
-
-
-
IOVA CLASS ACTION NEWS: BFA Law Notifies Iovance Biotherapeutics Investors with Losses to Contact the Firm by July 14 Legal Deadline
-
-
-
-
-
-
-
Scott+Scott Attorneys at Law LLP Alerts Investors of The Pending Class Action Against Iovance Biotherapeutics, Inc. (IOVA)
-
-
-
-
-
-
-
Iovance Biotherapeutics, Inc. Class Action: Levi & Korsinsky Reminds Iovance Biotherapeutics Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of July 14, 2025 - IOVA
-
1,231,053 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


